Have your own idea? Try our Stock Screener
Over the last 7 days, the Biotech industry has dropped 4.0%, driven by Regeneron Pharmaceuticals declining 9.6%. In the past year, the industry has gained 18%. Earnings are forecast to grow by 28% annually.
Has the U.S. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Fri, 27 Sep 2024 | US$885.6b | US$113.2b | -US$36,051,039,342.95 | 21.4x | -24.6x | 7.8x |
Sun, 25 Aug 2024 | US$908.6b | US$113.2b | -US$35,874,993,723.21 | 23.6x | -25.3x | 8x |
Tue, 23 Jul 2024 | US$1.2t | US$164.5b | -US$28,074,139,763.44 | 29.1x | -42.5x | 7.3x |
Thu, 20 Jun 2024 | US$1.1t | US$164.4b | -US$27,969,500,563.98 | 27.2x | -40.6x | 6.9x |
Sat, 18 May 2024 | US$1.1t | US$164.6b | -US$26,831,179,712.66 | 23.9x | -42.7x | 7x |
Mon, 15 Apr 2024 | US$1.1t | US$164.3b | -US$23,399,427,407.87 | 21.1x | -46.9x | 6.7x |
Wed, 13 Mar 2024 | US$1.2t | US$167.3b | -US$22,031,216,768.79 | 18.8x | -54.1x | 7.1x |
Fri, 09 Feb 2024 | US$1.2t | US$169.3b | -US$26,196,624,627.91 | 19.6x | -44x | 6.8x |
Sun, 07 Jan 2024 | US$1.4t | US$204.8b | -US$22,501,061,722.00 | 20.5x | -63.1x | 6.9x |
Tue, 05 Dec 2023 | US$1.3t | US$204.7b | -US$22,047,091,184.00 | 19x | -57.3x | 6.2x |
Thu, 02 Nov 2023 | US$1.2t | US$207.6b | -US$15,463,681,135.00 | 16.9x | -77.5x | 5.8x |
Sat, 30 Sep 2023 | US$1.3t | US$207.4b | -US$12,733,898,979.00 | 17.1x | -99.6x | 6.1x |
Mon, 28 Aug 2023 | US$1.3t | US$207.6b | -US$12,455,656,838.00 | 17.5x | -102.5x | 6.1x |
Wed, 26 Jul 2023 | US$1.1t | US$186.4b | -US$16,520,100,805.00 | 14.4x | -68.6x | 6.1x |
Fri, 23 Jun 2023 | US$1.1t | US$186.3b | -US$16,130,651,001.00 | 13.8x | -71.1x | 6.2x |
Sun, 21 May 2023 | US$1.2t | US$186.0b | -US$15,897,732,960.00 | 12.9x | -72.5x | 6.2x |
Tue, 18 Apr 2023 | US$1.2t | US$198.4b | -US$3,286,383,305.00 | 13.9x | -359.8x | 6x |
Thu, 16 Mar 2023 | US$1.1t | US$199.2b | -US$4,736,811,399.00 | 13.1x | -237.9x | 5.7x |
Sat, 11 Feb 2023 | US$1.2t | US$202.7b | -US$201,937,721.00 | 16.4x | -5723.2x | 5.7x |
Mon, 09 Jan 2023 | US$1.2t | US$203.3b | US$1.6b | 14.7x | 735.2x | 5.8x |
Wed, 07 Dec 2022 | US$1.1t | US$202.7b | US$1.4b | 14.8x | 802.1x | 5.6x |
Fri, 04 Nov 2022 | US$1.1t | US$206.0b | US$7.4b | 14x | 146.7x | 5.2x |
Sun, 02 Oct 2022 | US$1.0t | US$206.2b | US$5.4b | 14.9x | 189.9x | 4.9x |
Tue, 30 Aug 2022 | US$1.0t | US$206.2b | US$7.3b | 14.5x | 142x | 5x |
Thu, 28 Jul 2022 | US$1.1t | US$211.2b | US$11.2b | 16.4x | 96.6x | 5.1x |
Sat, 25 Jun 2022 | US$1.0t | US$212.4b | US$11.1b | 15.4x | 94.6x | 4.9x |
Mon, 23 May 2022 | US$1.0t | US$212.3b | US$10.9b | 15.1x | 92.4x | 4.8x |
Wed, 20 Apr 2022 | US$1.2t | US$226.6b | US$14.7b | 18.2x | 84.4x | 5.5x |
Fri, 18 Mar 2022 | US$1.3t | US$222.4b | US$10.6b | 19.5x | 119.4x | 5.7x |
Sun, 13 Feb 2022 | US$1.3t | US$216.3b | US$6.0b | 21.8x | 209.6x | 5.8x |
Tue, 11 Jan 2022 | US$1.4t | US$212.0b | US$2.7b | 24.9x | 504.4x | 6.4x |
Thu, 09 Dec 2021 | US$1.4t | US$212.0b | US$3.1b | 25.3x | 467.5x | 6.8x |
Sat, 06 Nov 2021 | US$1.5t | US$198.4b | -US$3,105,479,359.00 | 26.9x | -477.1x | 7.5x |
Mon, 04 Oct 2021 | US$1.5t | US$196.3b | -US$2,483,690,789.00 | 25.1x | -602.6x | 7.6x |
-602.6x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 0.60% | |
Healthcare | -1.58% | |
Biotech | -4.03% | |
Biotech | -4.03% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
SGEN Seagen | US$228.74 | 4.5% +US$1.8b | 76.5% | PS18.8x | |
BGNE BeiGene | US$212.53 | 7.0% +US$1.5b | 15.4% | PS7.3x | |
BNTX BioNTech | US$117.64 | 4.6% +US$1.2b | 15.3% | PS9.3x | |
GRPH Graphite Bio | US$22.26 | 539.7% +US$1.1b | 861.6% | PB7.1x | |
BHVN Biohaven | US$51.18 | 26.6% +US$1.0b | 96.8% | PB12.6x |